Literature DB >> 10830193

Nontraumatic brain hemorrhage in children: etiology and presentation.

A Al-Jarallah1, M T Al-Rifai, A R Riela, E S Roach.   

Abstract

The clinical and radiographic findings of 68 children and adolescents with nontraumatic intraparenchymal brain hemorrhage were analyzed retrospectively. There were 43 boys and 25 girls, and the average age was 7.1 years (range, 3 months to 18 years). The most common presenting symptom was a combination of headache or vomiting (40 cases, or 58.8%). Hemiparesis was the major presenting sign in 11 (16.2%) of the children, seizures occurred in 25 (36.8%) patients, and 6 (8.8%) children were irritable. Only 2 (2.9%) children were comatose at presentation. One or more risk factors for hemorrhage were found in 61 (89.7%) of 68 children. A third (23 cases, or 33.8%) had an arteriovenous malformation or fistula; altogether 29 (42.6%) children had some type of congenital vascular anomaly. Hematologic or coagulation disorders were present in 22 (32.4%) patients, and 9 (13.2%) patients had brain tumors. Hemorrhage could not be attributed to systemic hypertension in any child. The likelihood of establishing the cause of bleeding was greater when evaluation included cerebral angiography (97.3% versus 80.4% without angiography). Half (34 cases, or 50.0%) of the patients regained normal neurologic function. Six (8.8%) patients died, either directly or partly as a consequence of the hemorrhage. The remaining patients had various neurologic sequelae, including 17 (25.0%) with hemiparesis, 5 (7.4%) with aphasia, 7 (10.3%) with epileptic seizures, and 3 (4.4%) with hydrocephalus. More detailed follow-up studies are needed to obtain more information about the frequency of cognitive sequelae.

Entities:  

Mesh:

Year:  2000        PMID: 10830193     DOI: 10.1177/088307380001500503

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  30 in total

Review 1.  Childhood hemorrhagic stroke: an important but understudied problem.

Authors:  Warren D Lo
Journal:  J Child Neurol       Date:  2011-06-01       Impact factor: 1.987

2.  Multimodality treatment approach in children with cerebral arteriovenous malformation--a survey in the Danish population.

Authors:  Jane Skjøth-Rasmussen; Tina Obbekjær; Peter Birkeland; John Hauerberg; Marianne Juhler
Journal:  Childs Nerv Syst       Date:  2011-12-08       Impact factor: 1.475

3.  Stroke in Children.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-07       Impact factor: 3.598

Review 4.  Pediatric neurocritical care.

Authors:  Sarah Murphy
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

Review 5.  Hemorrhagic stroke in children.

Authors:  Lori C Jordan; Argye E Hillis
Journal:  Pediatr Neurol       Date:  2007-02       Impact factor: 3.372

Review 6.  Pediatric stroke: the importance of cerebral arteriopathy and vascular malformations.

Authors:  Lauren A Beslow; Lori C Jordan
Journal:  Childs Nerv Syst       Date:  2010-07-13       Impact factor: 1.475

Review 7.  Imaging of Pediatric Stroke.

Authors:  Aashim Bhatia; Sumit Pruthi
Journal:  Indian J Pediatr       Date:  2016-02-27       Impact factor: 1.967

8.  Cognitive functioning over 2 years after intracerebral hemorrhage in school-aged children.

Authors:  Lexa K Murphy; Bruce E Compas; Melissa C Gindville; Kristen L Reeslund; Lori C Jordan
Journal:  Dev Med Child Neurol       Date:  2017-09-06       Impact factor: 5.449

9.  Predictors of outcome in childhood intracerebral hemorrhage: a prospective consecutive cohort study.

Authors:  Lauren A Beslow; Daniel J Licht; Sabrina E Smith; Phillip B Storm; Gregory G Heuer; Robert A Zimmerman; Alana M Feiler; Scott E Kasner; Rebecca N Ichord; Lori C Jordan
Journal:  Stroke       Date:  2009-12-17       Impact factor: 7.914

10.  Intracerebral hemorrhage volume predicts poor neurologic outcome in children.

Authors:  Lori C Jordan; Jonathan T Kleinman; Argye E Hillis
Journal:  Stroke       Date:  2009-03-12       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.